Skip to content
Precision-Cut Tissue

Precision-Cut Tissue

Table of Contents

Definition

Precision-cut tissue slices (PCTS) are viable, three-dimensional ex vivo explants sectioned from fresh animal or human tissue to a reproducible, well-defined thickness.1 In metabolically active organs such as liver and lung, slices are cut at approximately 250 micrometres, which keeps every cell within the diffusion distance of oxygen and nutrients from the incubation medium.2 3 Because a slice retains the histoarchitecture of the parent organ—including its extracellular matrix, vascular and epithelial structures, and the full complement of resident parenchymal, stromal, and immune cells—it functions as a miniature model of the organ under study.1 4 Within this constraint, the tissue preserves the structural mechanics of the organ, including cell–cell and cell–matrix signalling, epithelial barrier geometry, and contractile elements such as airway smooth muscle, for days in culture.1 4

Purpose

The primary value proposition of PCTS is that they combine the experimental control, replication, and throughput of in vitro systems with a physiological fidelity that monolayer cultures cannot reproduce, since the native architecture and multicellular context of the organ remain intact.1 5 A single organ yields dozens of uniform slices, so one animal or one donor supplies many independent exposure conditions, dose–response series, and time courses; this directly reduces animal use in line with the 3R principles and improves internal statistical control relative to between-animal designs.4 6 The decisive advantage over legacy models is human relevance: slices can be prepared from human donor tissue, including diseased tissue, so pharmacology and toxicology are measured in the target species rather than extrapolated from an animal surrogate.7 8 Human precision-cut kidney slices have, for example, been proposed as the basis of an animal-free preclinical drug screening platform.7 PCTS thereby replace part of exploratory animal experimentation and improve upon dissociated-cell systems, which lose tissue architecture and the resident stromal and immune context during isolation.1 5

Methodology

Preparation begins with rapid procurement of fresh tissue, which is preserved in cold oxygenated buffer to minimize ischaemic injury.4 2 Cylindrical cores, typically 8 mm in diameter, are punched from the parenchyma and sectioned in a mechanical tissue slicer—the Krumdieck instrument, first described in 1980, or the Alabama Research and Development slicer—while the vibratome is increasingly used as an alternative cutting tool.4 2 For lung, the airspaces are inflated with low-melting-point agarose before sectioning to provide structural support and to maintain alveolar and airway geometry.3 Slices are transferred to multiwell plates in a defined, serum-supplemented medium—Williams’ Medium E is standard for liver—and incubated under gentle dynamic agitation to sustain oxygenation.4 2 Function is monitored with a standardized panel: ATP content and LDH release for viability, histomorphology for structural integrity, organ-specific outputs such as albumin and urea synthesis for liver slices, and gene and protein markers for pathway activation; exogenous stimuli such as TGF-β are applied to evoke fibrogenic responses in liver and intestinal slices.4 6 9 Human lung slices can additionally be cryopreserved and banked for on-demand use without loss of immune competence.10

Performance

In standard protocols, slices remain viable and metabolically competent for a 24 to 72 hour window that covers most acute exposure designs.4 2 With optimized culture, the functional window extends considerably: human lung slices can be maintained for up to two weeks3, cryopreserved human lung slices have been cultured for four weeks with preserved architecture and cellular viability10, and extended human liver slice cultures sustain regeneration-associated processes such as the ductular reaction over several days.11 Slice dimensions are highly uniform within and between preparations when a calibrated slicer is used, which was the principal rationale for introducing the Krumdieck instrument and remains the basis of quantitative dose–response work.2 The principal technical boundaries are the finite lifespan in culture, the inability to recruit non-resident immune cells such as circulating leukocytes, the diffusion-limited thickness that precludes organ-scale and vascular-level processes, donor-to-donor variability with human tissue, and residual batch-to-batch variation introduced during coring and cutting.2 3 10

Applications

PCTS are applied across four principal domains. In toxicology and ADME research, liver and intestinal slices are used for drug metabolism, transporter induction, and hepatotoxicity testing; rifampicin induces P-glycoprotein expression, protein, and activity in human intestinal slices12, and liver slices support drug-induced fibrosis and alcohol-related liver disease modelling6 8. In respiratory research, lung slices support airway contraction pharmacology, asthma, COPD, fibrosis, and drug discovery programs, including the evaluation of therapeutic interventions in slices prepared from in vivo disease models.3 5 13 In renal research, kidney slices serve as an ex vivo screening platform for antifibrotic therapeutics and as the basis of an animal-free human drug screening platform.7 14 Beyond these domains, slices are used in infection and host–pathogen biology1 and in studies of liver regeneration11. Deployment remains at the research and preclinical-adoption stage: the model is established in academic laboratories and pharmaceutical research groups, where it informs internal decision-making, but no regulatory test guideline is yet built on it.3 5

Variations

Precision-Cut Liver Slices — The most established subtype, used for hepatotoxicity, drug metabolism and transport, fibrosis, and alcohol-related liver disease modelling in human and rodent tissue.4 6 8

Precision-Cut Lung Slices — Preserve airway, vascular, and alveolar architecture for respiratory pharmacology, asthma and COPD research, fibrosis studies, and cryopreserved on-demand test systems.3 10 13

Precision-Cut Intestinal Slices — Retain full-thickness mucosal and muscularis architecture for ADME, transporter induction, and fibrogenesis studies in human tissue.12 9

Precision-Cut Kidney Slices — Support nephrotoxicity testing, antifibrotic drug screening, and epithelial integrity assessment in human renal tissue.7 14 15


  1. Majorova D, Atkins E, Martineau H, et al., Use of Precision-Cut Tissue Slices as a Translational Model to Study Host-Pathogen Interaction, Frontiers in Veterinary Science, 2021-06-04.
    This mini-review defines precision-cut tissue slices as three-dimensional explants that retain native organ architecture and cellular diversity, describes their preparation with mechanical slicers such as the Krumdieck and Alabama instruments, and surveys their application in host-pathogen research across human and animal organs. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  2. Zimmermann M, Lampe J, Lange S, et al., Improved reproducibility in preparing precision-cut liver tissue slices, Cytotechnology, 2009-12-20.
    This methods study describes the preparation of 8 mm liver cores sectioned to approximately 250 micrometres with the Krumdieck tissue slicer, documents residual sources of variability in slice thickness and compound absorption, and presents modifications that improve the reproducibility of slice dimensions and viability. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  3. Liu G, Betts C, Cunoosamy DM, et al., Use of precision cut lung slices as a translational model for the study of lung biology, Respiratory Research, 2019-07-19.
    This review, written with pharmaceutical industry authors, covers the practical generation of lung slices by agarose instillation and mechanical sectioning, their advantages for translational respiratory pharmacology, and their limitations, including a culture viability of up to two weeks and the inability to recruit non-resident immune cells. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  4. Dewyse L, Reynaert H, van Grunsven LA, Best Practices and Progress in Precision-Cut Liver Slice Cultures, International Journal of Molecular Sciences, 2021-07-01.
    This review traces the history of the technique from Carlos Krumdieck’s 1980 description of the tissue slicer, sets out best practices for the preparation, media, and culture of liver slices, and compares slicing instruments and viability readouts such as ATP content over multi-day cultures. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  5. Koziol-White C, Gebski E, Cao G, Panettieri RA, Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery, Respiratory Research, 2024-06-01.
    This review positions lung slices as an integrated ex vivo system that preserves tissue-level physiology for studies of lung physiology, pharmacology, disease pathogenesis including asthma, COPD, and fibrosis, and drug discovery across academic and industrial settings. ↩︎ ↩︎ ↩︎ ↩︎

  6. Dewyse L, De Smet V, Verhulst S, et al., Improved Precision-Cut Liver Slice Cultures for Testing Drug-Induced Liver Fibrosis, Frontiers in Medicine, 2022-03-30.
    This research article presents an optimized liver slice culture protocol in which TGF-β stimulation evokes fibrogenic responses in mouse and human slices, demonstrates readouts for drug-induced liver fibrosis testing, and situates the model within the 3R framework of replacement, reduction, and refinement. ↩︎ ↩︎ ↩︎ ↩︎

  7. Mutsaers HAM, Jensen MS, Kresse JC, et al., An animal-free preclinical drug screening platform based on human precision-cut kidney slices, BMC Research Notes, 2023-03-20.
    This note describes a preclinical drug screening platform built on human precision-cut kidney slices prepared from surgical tissue, outlines protocols for viability and toxicity readouts, and argues that human slices can replace animal-based screening in renal drug development. ↩︎ ↩︎ ↩︎ ↩︎

  8. Rastovic U, Bozzano SF, Riva A, et al., Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease, International Journal of Molecular Sciences, 2023-12-21.
    This review evaluates liver slices prepared from human donor tissue, including tissue with alcohol-related injury, as a platform for studying alcohol-related liver disease, and discusses viability, functionality, and disease-relevant readouts in slices cultured from human livers. ↩︎ ↩︎ ↩︎

  9. Biel C, Kastermans A, Heidema J, et al., Fibrogenesis in Human Mucosa and Muscularis Precision-Cut Intestinal Slices, Cells, 2024-06-22.
    This study characterizes fibrogenesis in full-thickness human intestinal slices prepared from mucosa and muscularis tissue, demonstrating TGF-β-driven fibrotic responses and supporting the use of intestinal slices as a human model for intestinal fibrosis. ↩︎ ↩︎

  10. Patel VS, Amin K, Wahab A, et al., Cryopreserved human precision-cut lung slices provide an immune competent pulmonary test system for “on-demand” use and long-term cultures, Toxicological Sciences, 2023-02-01.
    This study demonstrates that cryopreserved human lung slices retain immune competence, preserved lung architecture, and cellular viability after thawing, and reports four-week cultures with maintained viability, establishing an on-demand test system for repeated and long-term pulmonary toxicity studies. ↩︎ ↩︎ ↩︎ ↩︎

  11. Izunza Barba S, Rubio-Cruz D, Naz S, et al., Extended precision cut liver slice culture models liver regeneration and ductular reaction, eGastroenterology, 2026-04-29.
    This study extends human liver slice culture over multiple days and shows that slices from healthy and cirrhotic donors model regeneration-associated processes, including the ductular reaction, with metabolic measurements distinguishing donor disease states during the culture period. ↩︎ ↩︎

  12. Martinec O, Biel C, de Graaf IAM, et al., Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal Slices, Frontiers in Pharmacology, 2021-06-09.
    This study demonstrates that human precision-cut intestinal slices retain functional drug-metabolizing and transporter machinery, showing induction of P-glycoprotein gene expression, protein abundance, and transport activity after rifampicin exposure, and supports their use in ADME studies. ↩︎ ↩︎

  13. Lam M, Lamanna E, Organ L, et al., Perspectives on precision cut lung slices—powerful tools for investigation of mechanisms and therapeutic targets in lung diseases, Frontiers in Pharmacology, 2023-05-16.
    This review surveys lung slices as tools for investigating mechanisms and therapeutic targets in obstructive and fibrotic lung diseases, covering airway contraction assays, slices prepared from in vivo disease models, and the evaluation of therapeutic interventions targeting excessive airway narrowing. ↩︎ ↩︎

  14. Bigaeva E, Puerta Cavanzo N, Stribos EGD, et al., Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis, Pharmaceutics, 2020-05-18.
    This study establishes human and rodent precision-cut kidney slices as an ex vivo screening platform for antifibrotic therapeutics, demonstrating fibrogenesis readouts in cultured slices and evaluating the predictive value of the platform for human renal fibrosis. ↩︎ ↩︎

  15. Pedersen GA, Green BB, Merrild C, et al., Evaluation of Epithelial Integrity in Human Precision-Cut Kidney Slices, APMIS, 2026-04-01.
    This study evaluates epithelial integrity in human precision-cut kidney slices prepared from surgical tissue, validating markers and assays for segment-specific tubular injury, and supporting the use of human kidney slices for nephrotoxicity assessment. ↩︎